# DoorDash, Inc.: financial statements, quarterly DASH · Nasdaq · CIK 1792789 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/dash.md) · [Financials](/companies/dash/financials.md) · [Filings](/companies/dash/filings.md) · [Insiders](/companies/dash/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dash/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [2,164](/filings/0001628280-24-044312.md) | [2,303 d](/filings/0001792789-26-000035.md) | [2,513](/filings/0001628280-25-023171.md) | [2,630](/filings/0001792789-25-000012.md) | [2,706](/filings/0001792789-25-000020.md) | [2,873 d](/filings/0001792789-26-000035.md) | [3,032](/filings/0001792789-26-000037.md) | [3,284](/filings/0001792789-26-000050.md) | [3,446](/filings/0001792789-25-000020.md) | [3,955 d](/filings/0001792789-26-000035.md) | [4,036](/filings/0001792789-26-000037.md) | [4,454](/filings/0001792789-26-000050.md) | | Research and development | $m | [250](/filings/0001628280-24-044312.md) | [253 d](/filings/0001792789-26-000035.md) | [279](/filings/0001628280-25-023171.md) | [303](/filings/0001792789-25-000012.md) | [289](/filings/0001792789-25-000020.md) | [297 d](/filings/0001792789-26-000035.md) | [306](/filings/0001792789-26-000037.md) | [351](/filings/0001792789-26-000050.md) | [355](/filings/0001792789-25-000020.md) | [419 d](/filings/0001792789-26-000035.md) | [398](/filings/0001792789-26-000037.md) | [535](/filings/0001792789-26-000050.md) | | Operating income | $m | [(108)](/filings/0001628280-24-044312.md) | [(89.0) d](/filings/0001792789-26-000035.md) | [(61.0)](/filings/0001628280-25-023171.md) | [(201)](/filings/0001792789-25-000012.md) | [107](/filings/0001792789-25-000020.md) | [117 d](/filings/0001792789-26-000035.md) | [155](/filings/0001792789-26-000037.md) | [163](/filings/0001792789-26-000050.md) | [258](/filings/0001792789-25-000020.md) | [147 d](/filings/0001792789-26-000035.md) | [151](/filings/0001792789-26-000037.md) | [156](/filings/0001792789-26-000050.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [6.0](/filings/0001628280-24-044312.md) | [17.0 d](/filings/0001792789-26-000035.md) | [7.0](/filings/0001628280-25-023171.md) | [1.0](/filings/0001792789-25-000012.md) | [(6.0)](/filings/0001792789-25-000020.md) | [37.0 d](/filings/0001792789-26-000035.md) | [6.0](/filings/0001792789-26-000037.md) | [(13.0)](/filings/0001792789-26-000050.md) | [5.0](/filings/0001792789-25-000020.md) | [9.0 d](/filings/0001792789-26-000035.md) | [8.0](/filings/0001792789-26-000037.md) | [8.0](/filings/0001792789-26-000050.md) | | Net income | $m | [(73.0)](/filings/0001628280-24-044312.md) | [(154) d](/filings/0001792789-26-000035.md) | [(23.0)](/filings/0001792789-25-000020.md) | [(157)](/filings/0001792789-25-000020.md) | [162](/filings/0001792789-25-000020.md) | [141 d](/filings/0001792789-26-000035.md) | [193](/filings/0001792789-26-000050.md) | [285](/filings/0001792789-26-000050.md) | [244](/filings/0001792789-25-000020.md) | [213 d](/filings/0001792789-26-000035.md) | [184](/filings/0001792789-26-000050.md) | [200](/filings/0001792789-26-000050.md) | | Diluted EPS | $ per share | [(0.19)](/filings/0001628280-24-044312.md) | not reported | [(0.06)](/filings/0001628280-25-023171.md) | [(0.38)](/filings/0001792789-25-000012.md) | [0.38](/filings/0001792789-25-000020.md) | not reported | [0.44](/filings/0001792789-26-000037.md) | [0.65](/filings/0001792789-26-000050.md) | [0.55](/filings/0001792789-25-000020.md) | not reported | [0.42](/filings/0001792789-26-000037.md) | [0.46](/filings/0001792789-26-000050.md) | | Basic EPS | $ per share | [(0.19)](/filings/0001628280-24-044312.md) | not reported | [(0.06)](/filings/0001628280-25-023171.md) | [(0.38)](/filings/0001792789-25-000012.md) | [0.39](/filings/0001792789-25-000020.md) | not reported | [0.46](/filings/0001792789-26-000037.md) | [0.67](/filings/0001792789-26-000050.md) | [0.57](/filings/0001792789-25-000020.md) | not reported | [0.42](/filings/0001792789-26-000037.md) | [0.46](/filings/0001792789-26-000050.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [2.3](/filings/0001628280-24-044312.md) | [2.7](/filings/0001792789-26-000035.md) | [3.1](/filings/0001628280-25-023171.md) | [3.4](/filings/0001792789-25-000012.md) | [3.7](/filings/0001792789-25-000020.md) | [4.0](/filings/0001792789-26-000035.md) | [4.5](/filings/0001792789-26-000037.md) | [3.9](/filings/0001792789-26-000050.md) | [3.3](/filings/0001792789-25-000020.md) | [4.4](/filings/0001792789-26-000050.md) | [4.6](/filings/0001792789-26-000037.md) | [4.4](/filings/0001792789-26-000050.md) | | Current assets | $bn | [5.1](/filings/0001628280-23-035973.md) | [5.6](/filings/0001628280-25-005715.md) | [6.1](/filings/0001628280-24-019605.md) | [6.6](/filings/0001628280-24-034131.md) | [6.8](/filings/0001628280-24-044312.md) | [7.4](/filings/0001792789-26-000035.md) | [7.9](/filings/0001628280-25-023171.md) | [9.7](/filings/0001792789-25-000012.md) | [10.5](/filings/0001792789-25-000020.md) | [8.6](/filings/0001792789-26-000050.md) | [8.6](/filings/0001792789-26-000037.md) | [8.4](/filings/0001792789-26-000050.md) | | Total assets | $bn | [10.0](/filings/0001628280-23-035973.md) | [10.8](/filings/0001628280-25-005715.md) | [11.5](/filings/0001628280-24-019605.md) | [11.8](/filings/0001628280-24-034131.md) | [12.3](/filings/0001628280-24-044312.md) | [12.8](/filings/0001792789-26-000035.md) | [13.6](/filings/0001628280-25-023171.md) | [17.0](/filings/0001792789-25-000012.md) | [18.0](/filings/0001792789-25-000020.md) | [19.7](/filings/0001792789-26-000050.md) | [19.7](/filings/0001792789-26-000037.md) | [19.6](/filings/0001792789-26-000050.md) | | Current liabilities | $bn | [3.0](/filings/0001628280-23-035973.md) | [3.4](/filings/0001628280-25-005715.md) | [3.7](/filings/0001628280-24-019605.md) | [4.0](/filings/0001628280-24-034131.md) | [4.1](/filings/0001628280-24-044312.md) | [4.4](/filings/0001792789-26-000035.md) | [4.6](/filings/0001628280-25-023171.md) | [4.7](/filings/0001792789-25-000012.md) | [5.1](/filings/0001792789-25-000020.md) | [6.1](/filings/0001792789-26-000050.md) | [6.0](/filings/0001792789-26-000037.md) | [6.2](/filings/0001792789-26-000050.md) | | Total liabilities | $bn | [3.4](/filings/0001628280-23-035973.md) | [4.0](/filings/0001628280-25-005715.md) | [4.4](/filings/0001628280-24-019605.md) | [4.7](/filings/0001628280-24-034131.md) | [4.7](/filings/0001628280-24-044312.md) | [5.0](/filings/0001792789-26-000035.md) | [5.2](/filings/0001628280-25-023171.md) | [8.0](/filings/0001792789-25-000012.md) | [8.5](/filings/0001792789-25-000020.md) | [9.6](/filings/0001792789-26-000050.md) | [9.5](/filings/0001792789-26-000037.md) | [9.6](/filings/0001792789-26-000050.md) | | Shareholders' equity | $bn | [6.6](/filings/0001628280-24-044312.md) | [6.8](/filings/0001792789-26-000035.md) | [7.0](/filings/0001792789-25-000020.md) | [7.2](/filings/0001792789-25-000020.md) | [7.6](/filings/0001792789-25-000020.md) | [7.8](/filings/0001792789-26-000050.md) | [8.4](/filings/0001792789-26-000050.md) | [8.9](/filings/0001792789-26-000050.md) | [9.5](/filings/0001792789-25-000020.md) | [10.0](/filings/0001792789-26-000050.md) | [10.2](/filings/0001792789-26-000050.md) | [9.9](/filings/0001792789-26-000050.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [398 d](/filings/0001628280-24-044312.md) | [485 d](/filings/0001792789-26-000035.md) | [553](/filings/0001628280-25-023171.md) | [530 d](/filings/0001792789-25-000012.md) | [531 d](/filings/0001792789-25-000020.md) | [518 d](/filings/0001792789-26-000035.md) | [635](/filings/0001792789-26-000037.md) | [504 d](/filings/0001792789-26-000050.md) | [871 d](/filings/0001792789-25-000020.md) | [421 d](/filings/0001792789-26-000035.md) | [594](/filings/0001792789-26-000037.md) | [944 d](/filings/0001792789-26-000050.md) | | Capital expenditure | $m | [28.0 d](/filings/0001628280-24-044312.md) | [29.0 d](/filings/0001792789-26-000035.md) | [17.0](/filings/0001628280-25-023171.md) | [23.0 d](/filings/0001792789-25-000012.md) | [32.0 d](/filings/0001792789-25-000020.md) | [32.0 d](/filings/0001792789-26-000035.md) | [74.0](/filings/0001792789-26-000037.md) | [66.0 d](/filings/0001792789-26-000050.md) | [63.0 d](/filings/0001792789-25-000020.md) | [54.0 d](/filings/0001792789-26-000035.md) | [57.0](/filings/0001792789-26-000037.md) | [61.0 d](/filings/0001792789-26-000050.md) | | Share repurchases | $m | [6.0 d](/filings/0001628280-24-044312.md) | [51.0 d](/filings/0001792789-26-000035.md) | [0.0](/filings/0001628280-24-019605.md) | [7.0 d](/filings/0001792789-25-000012.md) | [217 d](/filings/0001792789-25-000020.md) | [0.0 d](/filings/0001792789-26-000035.md) | [0.0](/filings/0001792789-26-000037.md) | [0.0 d](/filings/0001792789-26-000050.md) | [0.0 d](/filings/0001792789-25-000020.md) | [0.0 d](/filings/0001792789-26-000035.md) | [162](/filings/0001792789-26-000037.md) | [887 d](/filings/0001792789-26-000050.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [385](/filings/0001628280-23-035973.md) | [390](/filings/0001628280-24-019605.md) | [389](/filings/0001628280-24-034131.md) | [393](/filings/0001628280-24-044312.md) | [405](/filings/0001628280-25-023171.md) | [410](/filings/0001792789-25-000012.md) | [428](/filings/0001792789-25-000020.md) | [436](/filings/0001792789-26-000037.md) | [438](/filings/0001792789-26-000050.md) | [442](/filings/0001792789-25-000020.md) | [442](/filings/0001792789-26-000037.md) | [439](/filings/0001792789-26-000050.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.